Non-pancreatic hyperlipasemia: A puzzling clinical entity

Table 6 Serum lipase and amylase levels according to the presence of complications in patients with acute pancreatitis (n = 392)

	No. of patients	Lipase (U/L)		Amylase (U/L)
		Median	IQR	Median	IQR
No complications	315	1287	577-2781	460	184-1064
Sepsis at all	56	1572	613-4588	485	199-1019
AKI at all	41	1370	511-4393	406	178-1381
AKI or sepsis	57	1529	611-4430	512	198-1123
Sepsis and AKI	20	1293	566-5175	447	188-1706
		P value		P value
None/sepsis at all		0.386		0.696
None/AKI at all		0.862		0.698
None/one (AKI or sepsis)		1.000		1.000
None/both (sepsis and AKI)		1.000		1.000

AKI: Acute kidney injury; AP: Acute pancreatitis; NPHL: Non-pancreatic hyperlipasemia; IQR: Interquartile range.